Phosphodiesterase-2 Inhibitor Bay 60-7550 Ameliorates Aβ-Induced Cognitive and Memory Impairment via Regulation of the HPA Axis

Procyanidins and Alzheimer’s Disease

(2019) Siqi Zhao et al.   MOLECULAR NEUROBIOLOGY

Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling

(2018) Ying Xu et al.   Frontiers in Aging Neuroscience

Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA/PKG-dependent neuro-inflammatory and apoptotic pathways

(2017) Li Wang et al.   Scientific Reports

New selective glucocorticoid receptor modulators reverse amyloid-β peptide–induced hippocampus toxicity

(2016) Fanny Pineau et al.   NEUROBIOLOGY OF AGING

The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling

(2016) Gang Wang et al.   Oncotarget

Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress

(2015) Ying Xu et al.   NEUROBIOLOGY OF AGING

Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: Involvement of antioxidant and anti-apoptotic mechanisms

(2014) Lianshu Ding et al.   BEHAVIOURAL BRAIN RESEARCH

Improved Long-Term Memory via Enhancing cGMP-PKG Signaling Requires cAMP-PKA Signaling

(2014) Eva Bollen et al.   NEUROPSYCHOPHARMACOLOGY

Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats

(2013) Charleine Zussy et al.   PLoS One

Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801

(2012) Olga A.H. Reneerkens et al.   BEHAVIOURAL BRAIN RESEARCH

Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway

(2012) Ying Xu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats

(2011) Charleine Zussy et al.   AMERICAN JOURNAL OF PATHOLOGY

The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats

(2011) Chuang Wang et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Involvement of the cholinergic system of CA1 on harmane-induced amnesia in the step-down passive avoidance test

(2011) Mohammad Nasehi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Are Phosphodiesterase Type 5 Inhibitors Associated with Vision‐Threatening Adverse Events? A Critical Analysis and Review of the Literature

(2011) Faris Azzouni et al.   Journal of Sexual Medicine

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress

(2009) Ying Xu et al.   NEUROPHARMACOLOGY

Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion

(2008) Eva L. van Donkelaar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY